A growing literature suggests that catecholamines and corticotropin-releasing factor (CRF) interact in a serial manner to activate the bed nucleus of the stria terminalis (BNST) to drive stress-or cue-induced drug-and alcohol-seeking behaviors. Data suggest that these behaviors are driven in part by BNST projections to the ventral tegmental area (VTA). Together, these findings suggest the existence of a CRF-signaling pathway within the BNST that is engaged by catecholamines and regulates the activity of BNST neurons projecting to the VTA. Here we test three aspects of this model to determine: (1) whether catecholamines modify CRF neuron activity in the BNST; (2) whether CRF regulates excitatory drive onto VTA-projecting BNST neurons; and (3) whether this system is altered by ethanol exposure and withdrawal. A CRF neuron fluorescent reporter strategy was used to identify BNST CRF neurons for whole-cell patch-clamp analysis in acutely prepared slices. Using this approach, we found that both dopamine and isoproterenol significantly depolarized BNST CRF neurons. Furthermore, using a fluorescent microsphere-based identification strategy we found that CRF enhances the frequency of spontaneous EPSCs onto VTA-projecting BNST neurons in naive mice. This action of CRF was occluded during acute withdrawal from chronic intermittent ethanol exposure. These findings suggest that dopamine and isoproterenol may enhance CRF release from local BNST sources, leading to enhancement of excitatory neurotransmission on VTA-projecting neurons, and that this pathway is engaged by patterns of alcohol exposure and withdrawal known to drive excessive alcohol intake.
Introduction
Addiction is a chronically relapsing disorder (Koob and Volkow, 2010) . Recent studies show that inactivation of the bed nucleus of the stria terminalis (BNST) reduces both stress-and cue-induced reinstatement to drug seeking (Buffalari and See, 2011) , suggesting that BNST activity is required for reinstatement. Catecholaminemediated activation of the BNST is critical for reinstatement, as stress increases norepinephrine (NE) release in the BNST (Pacak et al., 1995) and intracerebroventricular injections of NE induce reinstatement and increase BNST c-fos mRNA (Brown et al., 2011) , while ␤-adrenergic receptor (␤-AR) blockade in the BNST reduces reinstatement (Leri et al., 2002) . Further, ␤-AR activation in the BNST increases neuronal activity ex vivo (Egli et al., 2005; Nobis et al., 2011) .
In addition to its effects on NE and c-fos expression, stress exposure also increases corticotropin-releasing factor (CRF) mRNA in the BNST (Funk et al., 2006) . Intra-BNST injection of CRF induces reinstatement (Erb and Stewart, 1999) , while intra-BNST injection of CRF receptor antagonists blocks stressinduced reinstatement (Erb and Stewart, 1999; Wang et al., 2006) . Therefore, CRF may also increase BNST activity to induce reinstatement following a stressor. Furthermore, data suggest that NE-induced reinstatement is dependent on CRF signaling, while CRF-induced reinstatement is not dependent on AR signaling (Brown et al., 2009) .
These studies suggest that stress may drive reinstatement via a serial process involving catecholamine initiation of BNST CRF signaling. Supporting this hypothesis, ␤-AR and dopamine (DA) receptor activation enhances excitatory neurotransmission in the BNST through a CRFR1-dependent mechanism (Kash et al., 2008b; Nobis et al., 2011) . Recent findings using c-fos mapping suggest that BNST neurons projecting to the ventral tegmental area (VTA) (Georges and Aston-Jones, 2001; Massi et al., 2008) , a brain region important in drug-seeking behaviors, may be more likely to be activated during reinstatement than other BNST neurons (Briand et al., 2010) . Together, these data suggest a serial connection where catecholamines increase BNST CRF signaling, which in turn acts to enhance glutamatergic neurotransmission onto VTA-projecting BNST neurons to initiate reinstatement.
Although CRF signaling in the BNST is essential for relapse, the source of this CRF is not known as it could be released from local CRF neurons (Veinante et al., 1997) or from CRF-ergic afferents from other regions (Erb et al., 2001) . It is also not clear how manipulations of the BNST CRF system might alter the excitability of BNST projection neurons, especially reinstatementcritical BNST neurons that project to the VTA. Moreover, the above described studies have focused on reinstatement to cocaine or morphine. While previous evidence suggests a role of CRF signaling in binge drinking (Lowery et al., 2010) , ethanol (EtOH) withdrawal (Olive et al., 2002) , and stress-induced reinstatement to EtOH seeking (Lê et al., 2000; Marinelli et al., 2007) , no direct evidence indicates that chronic ethanol exposure can modulate neurocircuitry within the BNST that can potentially regulate reinstatement behaviors. Therefore, we sought to determine (1) whether catecholamines regulate CRF neurons in the BNST; (2) whether CRF modifies excitatory drive onto VTA-projecting BNST neurons; and (3) whether this system is altered by chronic intermittent ethanol exposure.
Materials and Methods

Animals
Two lines of mice were used in these studies. Seven-to twelve-week-old wild-type male C57BL/6J mice (The Jackson Laboratory) were used for all studies using retrograde tracer microinjections (n ϭ 51). A CRFtomato reporter line of mice was used to easily identify CRF neurons for electrophysiology recordings (for details see below, Characterization of CRF-tomato mouse line). To reduce the number of transgenic mice needed in these studies, both male and female 6-to 12-week-old CRFtomato mice were used (n ϭ 16). All mice were housed in groups of two to five for the duration of the studies. Food and water were available ad libitum. All procedures were approved by the Animal Care and Use Committee at Vanderbilt University (Nashville, TN).
Characterization of CRF-tomato mouse line
CRF-ires-cre mice were obtained from The Jackson Laboratory [strain B6(Cg)-Crhtm1(cre)Zjh/J, The Jackson Laboratory]. These mice were originally produced by the laboratory of Z. Josh Huang (Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) (Taniguchi et al., 2011) and have cre expression directed by the endogenous Crf promoter/enhancer elements. Upon arrival, CRF-ires-cre mice were then backcrossed for 1 generation further onto a C57BL/6J breeder line. Backcrossed CRF-ires-crepositive mice were then mated with a reporter line, ROSA-tomato (Madisen et al., 2010) [strain B6.Cg-Gt(ROSA)26SorϽtm14(CAG-tdTomato)HzeϾ/ J], in which a red (tomato) fluorescent protein is targeted to cre-containing cells. The resultant offspring, CRF-tomato mice, were then used for subsequent studies.
For anatomical characterization, three CRF-tomato mice were overdosed with Nembutal (100 mg/kg, i.p.) and perfused through the left ventricle of the heart with ice-cold PBS (10 ml) followed by cold 4% paraformaldehyde in PBS (20 ml). Brains were removed, postfixed for 24 h at 4°C in the same fixative, and then cryoprotected in PBS with 30% sucrose. Forty to fifty micrometer coronal sections of forebrain were cut on a cryostat (Leica CM 3050 S) and stored in PBS before fluorescent immunohistochemical staining. Free-floating brain sections containing the BNST, paraventricular nucleus of the hypothalamus (PVN), or central amygdala (CeA) were washed in PBS (4 ϫ 10 min), permeabilized with 0.5% Triton X-100 in PBS (30 min), and then blocked with 10% normal donkey serum in PBS containing 0.1% Triton X-100 (1 h); all steps were at room temperature. Sections were then incubated with primary antibody in blocking solution for 48 h at 4°C, followed by PBS washes (4 ϫ 10 min) and incubation with fluorescent dye-conjugated secondary antibodies for 24 h at 4°C in PBS with 0.1% Triton X-100. Finally, sections were washed (4 ϫ 10 min), mounted on slides, sealed with Aqua-Poly/Mount (Polysciences), and left overnight to dry. Stained sections of BNST, PVN, and CeA were imaged with a Zeiss 510 or 710 scanning confocal microscope. Images were analyzed with ZEN software (Carl Zeiss, Inc) or ImageJ (NIH). MetaMorph software (Invitrogen) was used to enhance contrast and overlay images when needed.
Identification of BNST neurons projecting to the VTA and hypothalamus
Retrograde tracer microinjections. On the day of surgery, C57BL/6J (6-to 9-week-old) mice were anesthetized with halothane (3% initial, 1.5% for maintenance) and placed in a stereotaxic apparatus (my NeuroLab, Leica). Angle Two software was used for setting injection targets within the VTA (coordinates were 3.2 mm posterior to bregma, 0.5 mm lateral to the midline, and 4.8 mm below the skull surface) and the medial areas of the hypothalamus (coordinates were 0.82 mm posterior to bregma, 0.19 mm lateral to the midline, and 4.95 mm below the skull surface, with the needle path angled 10°from the vertical plane). Other details about the surgical procedure have been described previously ). For retrograde labeling of BNST neurons projecting to the VTA, the 33 gauge needle of a 10 l syringe was heat sterilized immediately before back filling with an undiluted suspension of fluorescent microspheres (0.04 m diameter, red (580/605) or dark red fluorescent (660/680) FluoSpheres; Invitrogen). One hundred nanoliters of microsphere suspension was injected bilaterally at 10 nl/min using a UltraMicroPump II and Micro4 controller (World Precision Instruments). For retrograde labeling of BNST neurons that project to the hypothalamus, glass pipettes with tip diameters of 20 -40 m were filled with a freshly made 3% solution of Fluorogold (FG; Fluorochrome) dissolved in cacodylate buffer, inserted into the hypothalamus, and the FG was microiontophoresed with ϩ1.5 A in a 7 s on/7 s off cycle that lasted for 6 min. Ten minutes later, the pipette was withdrawn and the scalp wound was sutured closed. Postsurgical care included immediate subcutaneous saline (1.0 ml per 20 g of body weight) and analgesic (ketoprofen, 5 mg/kg, s.c.) followed by additional ketoprofen injections every 24 h for 3-4 days. Animals that lost Ͼ20% of their body weight or showed signs of uncontrolled pain, stress. or dehydration were euthanized. Six of fifty-one surgery animals were removed from the study for health concerns before experimentation. Healthy animals were used for anatomical (n ϭ 5 mice), electrophysiological (n ϭ 22) experiments 5-14 days after surgery or for chronic intermittent ethanol vapor chamber exposure and subsequent electrophysiological studies beginning 7-9 days after surgery (n ϭ 19). The hind brains of all tracer-injected mice used for whole-cell recordings were immersion fixed in 4% paraformaldehyde/PBS, cryoprotected with 30% sucrose, and sectioned on a cryostat. Sections were mounted on slides and imaged with a fluorescence microscope (Nikon AZ100M).
Retrograde tracer localization. Methods for anatomical experiments of tracer-injected mice were identical to those described in the previous section for anatomical characterization of CRF-tomato mice. No primary antibody control sections from uninjected mice were used to show negligible nonspecific fluorescent signal from secondary antibodies and autofluorescence at microscope configurations used for collecting images. Control sections from tracer-injected mice, either unstained or stained with a single fluorophore, were used to show no significant crosstalk between fluorophores at microscope configurations used for collecting multicolor images. There was no bleed through of the native fluorescence of FG when bound to primary and secondary antibodies and then imaged with the microscope configuration used for NeuN/Cy2. Hypothalamus and VTA fluorescent tracers were examined in the BNST. The degree of potential fluorophore colocalization within the BNST was determined by assessing the total number of fluorescent-labeled cells in three successive BNST slices and determining the percentage of cells in which fluorescent markers overlapped in the group of labeled neurons. Cell counts were done with the aid of ImageJ or MetaMorph software. All animals with retrograde-labeled BNST neurons reported here were confirmed to have tracer injection sites in the VTA and/or hypothalamus (Fig. 3C,D for examples of injection sites).
Chronic intermittent ethanol vapor chamber exposure paradigm
Sham and chronic intermittent ethanol (CIE) mice were given a daily injection of pyrazole (1 mmol/kg) to impair the metabolism of ethanol. Thirty minutes after the injection, mice in their home cages were placed in a chamber filled with volatilized ethanol (CIE; 20.3 Ϯ 0.2 mg/L) or volatilized water (sham). In a different cohort of mice, 60 mg/kg NBI27914 was included with the daily pyrazole injections to test the effect of a CRFR1 antagonist on CIE-induced alterations to BNST excitatory neurotransmission. Airflow through the chambers was maintained at 5.5 L/min, and volatilization was maintained at 1.5 L/min. Using these parameters, we can reliably obtain blood ethanol concentrations in the range of 150 -185 mg/dl (Healey et al., 2008) . After 16 h of exposure, mice were removed from the chambers and returned to standard animal housing facility. Mice were given two 4 day cycles of vapor chamber exposure (16 h in chambers per day, 8 h standard housing per day) separated by a 3 day period where they were maintained solely in standard animal housing facility. On the last day of the second CIE cycle the mice were returned to the standard animal housing facility for 4 h before being used for electrophysiology.
Brain slice preparation and electrophysiology
Three hundred-micrometer-thick brain slices containing the BNST (bregma, 0.14 -0.26) were prepared from 7-12 week old C57BL/6J mice or from 6 -12 week old CRF-tomato mice as described previously (Kash et al., 2008b; Nobis et al., 2011) . Following dissection, slices were transferred to a holding chamber where they were heated (27-30°C) and were allowed to equilibrate for at least 1 h before being transferred to a submerged perfusion chamber (also heated to 27-30°C) for whole-cell, patch-clamp recordings. All electrophysiology recordings were made using Clampex 9.2 and analyzed using Clampfit 10.2 (Molecular Devices). Whole-cell, voltage-clamp recordings of AMPA receptor-mediated spontaneous excitatory postsynaptic currents (sEPSCs) were made at Ϫ70 mV and pharmacologically isolated by the addition of 25 M picrotoxin to the artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 4.4 KCl, 2 CaCl 2 , 1.2 MgSO 4 , 1 NaH 2 PO 4 , 10 glucose, and 26 NaHCO 3 . Cells were allowed to equilibrate to whole-cell configuration for 3-5 min before recordings began. sEPSC recordings were acquired and analyzed in 2 min gap-free blocks. Cells in which the frequency was below 0.2 Hz were not included in the data analysis. Access resistance was monitored between blocks of sEPSC recordings. Those experiments in which the access resistance changed by Ͼ20% were not included in the data analyses. Recording electrodes for voltage-clamp experiments were filled with (in mM): 118 CsOH, 117 D-gluconic acid, 5 NaCl, 10 HEPES, 0.4 EGTA, 2 MgCl 2 , 5 tetraethylammonium chloride, 4 ATP, 0.3 GTP, pH 7.2-7.3, 280 -290 mOsmol. For experiments in which the effects of antagonists were determined, the antagonist was pre-applied for at least 12 min before application of a test drug and then remained onboard for the duration of the experiment. Whole-cell, current-clamp recordings were performed without the addition of picrotoxin to the ACSF and were carried out at each neuron's resting membrane potential after allowing at least 3 min for the cell to equilibrate and for the resting membrane potential to stabilize. Recording electrodes for current-clamp experiments were filled with (in mM): 135 K ϩ -gluconate, 5 NaCl, 2 MgCl 2 , 10 HEPES, 0.6 EGTA, 4 ATP, 0.4 GTP, pH 7.2-7.3, 280 -290 mOsmol. Current-clamp experiments analyzing the effect of drugs on resting membrane potential were recorded continuously in gap-free mode for the duration of the experiment.
Statistical analyses
Statistical analyses were performed using Microsoft Excel 2010 and GraphPad Prism 5, while figures were finalized in CorelDRAW 12. Specifically, when determining whether a compound had a significant effect, a Student's paired t test was used, comparing the baseline value to the experimental value. To compare the effects of different concentrations of drugs on sEPSCs, a one-way ANOVA was used followed by Tukey's post-test to determine the significance of specific comparisons. All values given for drug effects throughout the study are presented as average Ϯ SEM.
Drugs
Isoproterenol, CRF, and NBI27914 were purchased from Tocris Bioscience. All other compounds and experimental drugs were purchased from Sigma-Aldrich unless otherwise noted in the text. All experimental drugs were bath applied at their final concentrations as noted in the text. Dimethylsulfoxide (DMSO) was the solvent used for stock solutions of NBI27914 and picrotoxin where the maximum final concentration of DMSO in ACSF was 0.02% by volume.
Reagents
Primary antibodies used included rabbit polyclonal anti-Fluorogold antibody (used at 1:3000 dilution) and mouse monoclonal anti-neuronal nuclei antibody (NeuN, used at 1:1000 dilution), both from Millipore Bioscience Research Reagents. Secondary antibodies were purchased from Jackson ImmunoResearch Laboratories and included Cy2-conjugated donkey anti-mouse (1:400), Dylight 649-conjugated donkey anti-rabbit (1:1000), and Cy3-conjugated donkey anti-rabbit (1:1000) Fab fragments. Figure 1 shows the pattern of tomato expression in selected brain regions. Tomato expression was most dense in regions known to have a high density of CRF-producing neurons like the PVN, BNST, and CeA ( Fig. 1 A-C, green cells) , while brain regions such as the cortex or striatum, known to have very limited number of CRF-producing neurons, had very sparse expression of tomato. We next assessed the basal properties of the CRF-tomato neurons in the BNST by using current-clamp recordings. Initial analysis revealed a wide range of basal resting membrane potentials. In 23 cells tested, resting membrane potentials of BNST CRF neurons ranged from Ϫ71 to Ϫ43 mV (Fig. 1 F) .
Results
Electrophysiological properties of CRF neurons in the extended amygdala
Previous reports indicate that neurons in the rat and mouse BNST can be categorized into at least three distinct neuronal subtypes based on voltage responses to transient current steps (Egli and Winder, 2003; Hammack et al., 2007) . We therefore assessed whether CRF neurons in the mouse BNST could be categorized into similar neuronal subtypes (n ϭ 13 mice). Voltage responses were assessed in response to incremental current steps (ranging from Ϫ120 pA to ϩ120 pA) of 1500 ms in duration (Table 1) . Using the categorization strategy of Hammack et al. (2007) , 10 of 23 neurons tested in this manner fit into previously described categories (I-III) of rat BNST neurons (for examples, Fig. 1 D) . The remaining 13 neurons could not be placed into any of the predefined group based on their voltage responses (for examples, Fig. 1 E) . For example, these cells did not have a "hyperpolarizing sag" like that seen in type I and type II neurons. In addition, they had a significantly shorter latency to firing first action potentials in response to a suprathreshold current injection compared to type III neurons (see Table 1 for values; t (12) ϭ 5.628, p Ͻ 0.0001). Ten of these thirteen cells fired only one action potential per depolarizing current injection even in response to the largest current injections tested (ϩ120 pA). The remaining three cells did have multiple action potentials at very positive current injection levels after firing only once at lower current levels (Fig. 1 E) . In addition, 6 of13 of these neurons had a transient depolarizing rebound action potential upon termination of the hyperpolarizing current injection (data not shown). Subsequent analysis revealed that CRF neurons with a rebound action potential rested at significantly more depolarized membrane potentials than non-rebounders (rebound vs non-rebound: Ϫ54.8 Ϯ 2.4mV vs Ϫ66.3 Ϯ 1.7mV, t (11) ϭ 3.988, p Ͻ 0.005). Interestingly, all neurons that had this rebound action potential upon termination of hyperpolarizing current injections fired only one action potential in response to suprathreshold current injections.
For comparison, we performed the same analysis on CRFtomato neurons from the CeA of the same mice tested above. Analysis revealed that CeA CRF neurons are significantly different that BNST CRF neurons in many of their basal properties (Table 1) . Resting membrane potentials for CeA CRF neurons were significantly more hyperpolarized than the averaged resting membrane potential of all BNST CRF neurons (Ϫ72.5 Ϯ 1.2mV vs Ϫ59.8 Ϯ 2.2mV, respectively; t (27) ϭ 6.368, p Ͻ 0.0001; Fig.  1 F) . However CeA CRF neurons may be more similar in nature to type III BNST CRF neurons as they both have longer latency to fire compared to any other group (ANOVA, F (2,30) ϭ 5.525, p Ͻ 0.01), but post hoc analysis revealed that these two cell types do not have significantly different latencies from each other (Tukey's multiple-comparison test, q ϭ 1.09, p Ͼ 0.05). Moreover, CeA CRF neurons seemed to also have more homogeneous voltage responses to current injections, as hyperpolarizing currents caused inwardly rectifying voltage responses in all CeA CRF neurons. In addition, these neurons were either regularly firing or burst firing in response to suprathreshold-positive current injections (Fig. 1G ).
Dopamine and isoproterenol depolarize CRF neurons in the BNST
Our previous reports indicate that DA and the ␤-AR agonist isoproterenol (ISO) can enhance glutamatergic transmission in the BNST via a CRF-dependent mechanism (Kash et al., 2008b; Nobis et al., 2011) . In exploring the mechanisms underlying these actions, we found that the effect of DA was activity dependent, and that DA depolarized a subpopulation of BNST neurons of unknown type (Kash et al., 2008a) . This led us to hypothesize that DA and ISO may produce CRF-dependent increases in excitatory transmission in the BNST by depolarizing CRF interneurons. Therefore, we next assessed whether DA and ISO depolarize BNST CRF-tomato neurons. Following a 5 min baseline period in which tomato ϩ neurons were monitored at their resting membrane potentials, 3 M ISO or 1 M DA was bath applied (Fig.  2A) . The concentrations of DA and ISO used in this study were previously shown to enhance sEPSC frequency in a CRFR1-dependent manner in the BNST (Nobis et al., 2011) .
A 6 min bath application of DA significantly depolarized BNST CRF neurons (a change of ϩ3.4 Ϯ 0.6mV compared to baseline, t (7) ϭ 6.144, n ϭ 8, p Ͻ 0.001; Fig. 2B ). The level of DA-induced depolarization of BNST CRF neurons was not significantly correlated with their initial basal resting membrane potential (R 2 ϭ 0.014; p Ͼ 0.05; Fig. 2C ). The peak effect of DA occurred within 2-5 min post-DA removal, and this effect continued to be significant throughout the duration of the recording (change in membrane potential 15-18 min following the removal of DA: ϩ2.5 Ϯ 1.0mV compared to baseline, t (7) ϭ 2.528, p Ͻ 0.05; Fig. 2B) . A paired t test revealed no significant difference in the level of DA-induced depolarization at peak or at the end of the recording (2-5 min post-DA vs 15-18 min post-DA, t (7) ϭ 1.756, p ϭ 0.12).
A 10 min bath application of ISO also significantly changed the resting membrane potentials of BNST CRF neurons to a more depolarized level (a change of ϩ4.5 Ϯ 1.4mV compared to baseline, t (11) ϭ 3.262, n ϭ 12, p Ͻ 0.01; Fig. 2B ). This depolarization effect peaked at 2-5 min after the removal of ISO, and the level of ISO depolarization also did not significantly correlate with basal resting membrane potential (R 2 ϭ 0.03, p Ͼ 0.05; Fig. 2D ). However, in a subset of cells tested, the level of ISO-induced depolarization was significantly correlated with an increase in input resistance (R 2 ϭ 0.8, p Ͻ 0.05, Fig. 2E ). The effect of ISO was long lasting, as a paired t test revealed no significant difference in the level of ISO-induced depolarization at peak or at the end of the recording (t (11) ϭ 1.601, p Ͼ 0.14).
Microsphere labeling of BNST projection neurons
The above data suggest that catecholamines enhance BNST CRF neuron activity, potentially leading to increased excitability of BNST projection neurons. It is unclear whether different populations of BNST neurons project to specific targets or whether a single population of BNST neurons might simultaneously project to multiple brain regions. For this reason, we microinjected spectrally distinct retrograde tracers into two important target regions of the BNST, the hypothalamus and the VTA, and tested for colocalization of these tracers in the BNST with confocal microscopy. Medial aspects of the hypothalamus were targeted as this area contains the paraventricular nucleus, and projections from the BNST to this brain region are thought to be important in stress-related behaviors (Jankord and Herman, 2008; Radley and Sawchenko, 2011) . The VTA was chosen for its role in drugseeking behavior (You et al., 2007) and the potential importance of BNST projections to the VTA in reinstatement (Briand et al., 2010) . The BNST slices used for confocal microscopy were at the same level used in other portions of this study for electrophysiology. Fluorogold was microinjected into the hypothalamus, and red/infra-red fluorescent latex microbeads were injected into the ipsilateral VTA (for examples of injection sites, Fig. 3C,D) . NeuN was used as a pan-neuronal marker in BNST slices to ensure that retrograde tracers were specifically filling neurons (Fig.  3A) . Colocalization analysis revealed that only ϳ1% of VTAprojecting neurons also colabeled as projecting to the hypothalamus, and ϳ5% of hypothalamus neurons also colabeled as projecting to the VTA (Table 2) . Overall, these findings suggest that BNST neurons projecting to the VTA may be largely distinct from BNST neurons projecting to the medial aspects of the hypothalamus.
Electrophysiological properties of VTA-projecting BNST neurons
Since the VTA plays a well characterized role in drug-seeking behaviors and since BNST neurons that project to the VTA have been proposed to become active during reinstatement (Briand et al., 2010) , we chose to focus our electrophysiological analysis on VTA-projecting BNST neurons. Previous reports suggest that the electrophysiological properties of projection neurons in the rat BNST can be distinct from BNST interneurons (Dumont and Williams, 2004; Kash et al., 2008a) , suggesting that VTAprojecting BNST neurons could potentially all be classified into one of the previously described subtypes (Hammack et al., 2007) . In eight cells tested from five animals using current-clamp recording conditions similar to those in Figure 2 , we found evidence of three different types of VTA-projecting BNST neurons; two neurons were similar to type I neurons, two were similar to type II neurons, and four neurons were similar to "other" neurons characterized above (see Fig. 3B and Table  3 ). Interestingly, in this limited sample we did not find any VTA-projecting BNST neurons to be classified as type III neurons.
CRF enhances sEPSC frequency on VTA-projecting BNST neurons
Since DA and ISO were able to significantly depolarize BNST CRF neurons, we next wanted to determine how enhanced CRF levels might alter the activity of VTA-projecting BNST neurons. We performed whole-cell voltage-clamp recordings in these neurons and determined the effect of exogenously applied CRF on sEPSCs. Bath application of CRF (10 nM-1 M, n ϭ 3-6 cells per concentration) enhanced sEPSC frequency in a concentration-dependent manner (ANOVA, F (3,14) ϭ 9.329, p Ͻ 0.005; Fig. 4 A, B) , suggesting that CRF enhances presynaptic glutamatergic release onto VTA-projecting BNST neurons. There were no significant effects of CRF on sEPSC amplitude at any concentration tested (F (3,14) ϭ 1.972, p ϭ 0.16, Fig. 4C ). In addition, there were no significant effects of CRF on sEPSC area, rise time, decay time, holding current, or membrane resistance at any concentration tested (data not shown). To determine which CRF receptor subtype was mediating this effect, we pretreated a separate group of slices with the CRFR1 selective antagonist NBI27914 (NBI, 1 M). While NBI had no significant effect on its own on basal sEPSC frequency compared to control slices [control (n ϭ 18) vs NBI (n ϭ 6): 1.8 Ϯ 0.5 vs 3.1 Ϯ 0.7 (Hz); t (22) ϭ 1.429, p ϭ 0.17], pretreatment with NBI significantly blocked the ability of 300 nM CRF to enhance sEPSC frequency [300 nM CRF vs NBI ϩ 300 nM CRF (n ϭ 5 per group): 139.5 Ϯ 13.0 vs 100.0 Ϯ 9.8% (expressed as percent of baseline), t (8) ϭ 2.426, p Ͻ 0.05; Figure 4D ], suggesting that CRF-mediated enhancement of sEPSC frequency in VTA-projecting BNST neurons involves activation of CRFR1.
Chronic intermittent ethanol enhances basal glutamatergic tone in the BNST and occludes the effect of exogenous CRF
We next sought to determine how exposure and withdrawal from chronic ethanol might alter the ability of CRF to modulate glu- tamate release onto VTA-projecting BNST neurons. Tracer-injected mice received 2 weeks of chronic intermittent ethanol vapor chamber exposure as described previously (Wills et al., 2012) . This regimen has previously been demonstrated to enhance alcohol-seeking behavior (Becker and Lopez, 2004; Griffin et al., 2009) . On the last day of CIE exposure, mice were allowed to go through 4 -5 h of withdrawal before slicing. Sham mice received the same treatment design, except they never received ethanol. Since repeated transferring of sham mice between the colony room and the vapor chamber room as well as the daily injections of pyrazole could be a stressor, we first sought to confirm that sham mice were not different from their naive counterparts. We recorded from VTAprojecting BNST neurons and found that basal sEPSC frequency was not significantly different in sham mice versus naive mice (1.8 Ϯ 0.4 vs 1.8 Ϯ 0.5 Hz, n ϭ 7 and 18 respectively, t (23) ϭ 0.035, p ϭ 0.97; Fig. 5A ). In addition, 300 nM CRF significantly enhanced sEPSC frequency in sham mice in a similar manner as naive mice [161.3 Ϯ 15.6% vs 139.5 Ϯ 13.0%, respectively (percent of baseline); n ϭ 5/group; CRF effect in sham mice compared to baseline, t (4) ϭ 3.89, p Ͻ 0.05; CRF effects in sham vs naive mice, t (8) ϭ 1.066, p ϭ 0.32]. Therefore, we decided to group sham and naive mice for comparison to CIE mice. Basal sEPSC frequency was enhanced in VTA-projecting BNST neurons from CIE mice compared to sham/naive mice (3.4 Ϯ 0.6 vs 1.8 Ϯ 0.4 Hz, n ϭ 12 and 25 respectively, t (35) ϭ 2.385, p Ͻ 0.05; Fig. 5B ), suggesting that glutamatergic tone onto VTAprojecting BNST neurons is enhanced in CIE mice during acute withdrawal time points. CIE did not cause any significant changes to basal sEPSC amplitude compared to naive or sham groups (ANOVA, F (2,35) ϭ 1.948, p ϭ 0.16). Furthermore, from this enhanced level of glutamatergic tone, 300 nM CRF no longer could significantly alter sEPSC frequency in VTA-projecting BNST neurons [300 nM CRF-induced change 83.8 Ϯ 7.3% (percent of baseline, n ϭ 5); 300 nM CRF effect in CIE group compared to baseline, t (4) ϭ 2.223, p ϭ 0.09; effect of 300 nM CRF in CIE compared to sham/ naive, t (13) ϭ 4.258, p Ͻ 0.001; Figure 5C ], suggesting that CIE may modulate BNST CRF signaling in vivo. To test the hypothesis that CIE-induced changes to basal sEPSC frequency in VTA-projecting BNST neurons occur through a CRFR1-dependent mechanism, tracer-injected mice were treated with daily injections of NBI before CIE or sham exposures (Fig. 5D,E) . Daily NBI injections did not significantly alter basal sEPSC frequency in VTA-projecting BNST neurons in sham ϩ NBI animals compared to the previous naive/ sham group (sham ϩ NBI vs naive/sham: 2.2 Ϯ 0.3 vs 1.8 Ϯ 0.4, n ϭ 6 and 26 respectively, t (29) ϭ 0.4827, p ϭ 0.63). Importantly, in mice treated with NBI before CIE exposure, CIE did not cause a significant increase in basal sEPSC frequency in VTA-projecting BNST neurons compared to sham ϩ NBI (CIE ϩ NBI vs sham ϩ NBI: 2.0 Ϯ 0.7 vs 2.2 Ϯ 0.3, n ϭ 6/group, t (10) ϭ 0.2147, p ϭ 0.83). Together, these findings suggest that CIE modulates in vivo CRF activity in the BNST through a CRFR1-dependent mechanism and that during acute withdrawal BNST CRFR1 may be maximally active.
Discussion
Stress-induced reinstatement is hypothesized to occur via increased BNST excitability, likely through catecholamine and CRF signaling interactions within BNST (Brown et al., 2009; Briand et al., 2010; Buffalari and See, 2011) . Here we used a combination of strategies to elucidate a potential mechanism by which catecholamines may influence CRF activity to enhance BNST excitatory neurotransmission, and we show that this system is modulated by chronic ethanol exposure. Our data show that catecholamines can depolarize BNST CRF neurons, potentially leading to increased CRF release. In turn, CRF enhances glutamatergic transmission onto VTA-projecting BNST neurons, suggesting that elevated extracellular CRF in the BNST may modulate neurocircuitry critical to drug-seeking behavior. Importantly, CIE increases basal glutamatergic tone onto VTAprojecting BNST neurons and occludes the effect of CRF. This effect of CIE can be blocked by pretreating EtOH exposed mice with a CRFR1 antagonist, suggesting that CIE modulates BNST CRF neurocircuitry in vivo and that this neurocircuit can become hyperactive during withdrawal. Together, these findings suggest the BNST contains an ethanol-sensitive circuit wherein elevated catecholamines increase CRF neuron activity to enhance excitatory transmission onto BNST neurons projecting to the VTA (Fig. 6, summary model) .
Electrophysiological properties of BNST neurons
Previous reports indicate that BNST neurons may be classified into distinct subtypes based on electrophysiologic properties. In the rat BNST, three different classes of neurons have been described based on membrane voltage responses to current injections (Hammack et al., 2007) . In addition, BNST projection neurons in the rat may be distinguished from local interneurons based on the presence of Ih currents (Dumont and Williams, 2004) . Therefore, it could be hypothesized that BNST neurons classified by protein content or terminal projections may have homogenous electrophysiologic properties, information that could then be used to identify specific BNST neuronal subpopulations without needing prior genetic or surgical manipulations. However, the data presented here suggest that this may not be the case. Our data indicate that there are at least four electrophysiologically separable subtypes of CRF neurons and three types of VTA-projecting neurons in the mouse BNST. The presence of at least four categories of electrophysiologically distinct categories of BNST neurons is more than previously described and could be due to differences in rat and mouse BNST physiology, differences in recording sites within the slice, or differences in recording conditions. However, CeA CRF neurons seem much more homogenous in nature than BNST CRF neurons recorded under similar conditions, suggesting that our recording conditions are not a major factor in BNST neuron subtype variability. Indeed, differences between BNST neuronal subtypes may to some degree be due to one neuronal subtype recorded during different activation states, although evidence does suggest unique mRNA profiles (Hammack et al., 2007) . These data point to the use of fluorescent markers based on neuronal protein content or terminal projections as an important approach to study specific BNST neuron subpopulations.
Catecholamine effects on BNST CRF neurons
We have previously shown that DA and ISO can enhance sEPSC frequency in the BNST in an activity-dependent manner (Kash et al., 2008b; Nobis et al., 2011) . This effect can be mimicked by application of CRF and blocked by pretreatment with a CRFR1 antagonist, suggesting that catecholamine effects on BNST excitatory transmission require CRF receptor activation, possibly by increasing CRF release from local sources. To record specifically from CRF neurons in the BNST, we crossed two lines of commercially available mice to create the CRF-tomato line, which expresses a red fluorescent protein specifically in CRF neurons. The expression of red fluorescent protein in these mice is most dense in brain regions that have high levels of CRF-producing neurons, like the PVN, BNST, and CeA. In recordings from these mice, we found that DA and ISO caused significant and prolonged depolarization of BNST CRF neurons. Importantly, the time course of DA and ISO depolarization of CRF neurons is similar to the time course of activity-dependent DAand ISO-induced increases of glutamatergic transmission in the BNST (Kash et al., 2008b; Nobis et al., 2011) , suggesting that catecholamine enhancement of BNST excitability may be due to increased CRF release from local BNST neurons.
BNST activity is necessary for reinstatement to drug seeking ( (Erb and Stewart, 1999; Funk et al., 2006; Wang et al., 2006) to initiate reinstatement. The data presented here expand on this hypothesis and suggest that catecholamine-CRF neurocircuit interactions in the BNST may be an important locus for initiation of stress-induced reinstatement.
While the role for BNST ␤-ARs in reinstatement is well characterized, a potential role of BNST DA in reinstatement is much less clear. Amygdala DA signaling has been shown to be important in cue-induced reinstatement to drug seeking (Berglind et al., 2006) , but the role of BNST DA in reinstatement has not yet been tested. However, inactivation of the BNST has been shown to reduce cue-induced reinstatement of cocaine seeking (Buffalari and See, 2011) , and rewarding stimuli have been shown to increase extracellular DA in the BNST (Carboni et al., 2000; Park et al., 2012) , which would likely increase BNST excitation based on our data. Together, these findings suggest a possible role of BNST DA activity in cue-induced reinstatement. Recent evidence suggests that DA can be released from NE terminals due to amphetamine-induced alterations in NE transporter activity, at least in the hippocampus (Smith and Greene, 2012) . NE transporters in the BNST can become upregulated after chronic cocaine self-administration (Macey et al., 2003) , suggesting that drug-induced alterations in BNST could also alter extracellular NE and/or DA levels through NE transporters. Our data indicate that DA can depolarize BNST CRF neurons, similar to ␤-AR activation. Since NE terminals in the BNST likely become activated during stress (Pacak et al., 1995) , these findings suggest DA may also be released in the BNST following stress after drug exposure and further suggest a potential role of BNST DA in stressinduced reinstatement. CRF and CIE increase excitatory drive onto BNST neurons projecting to the VTA The BNST has widespread projections that can regulate a variety of behaviors, such as stress and reward (Dong et al., 2001; Dong and Swanson, 2004; Dong and Swanson, 2006; Ulrich-Lai and Herman, 2009) . However, it is not clear whether distinct populations of BNST neurons project to one specific brain region or whether a single BNST neuron may project to multiple downstream targets simultaneously. Here, we provide initial evidence that BNST neurons projecting to the hypothalamus and VTA, two well characterized BNST targets, likely only partially overlap, suggesting that distinct pools of BNST projections neurons may independently regulate circuitry involved in reward and/or stress behavior.
Supporting this hypothesis, previous reports indicate that reinstatement increases neuronal markers of activation specifically in BNST neurons that project to the VTA (Briand et al., 2010) . The data presented here are in agreement with these previous findings and suggest that CRF may be an important modulator of excitatory drive onto VTA-projecting BNST neurons. We find that acute withdrawal from CIE can enhance basal glutamatergic tone onto VTA-projecting BNST neurons but occlude the effect of exogenous CRF. Additionally, the CIE enhancement of basal glutamatergic tone is blocked by pretreatment with a CRFR1 antagonist. These data are in agreement with previous work indicating that extracellular CRF is elevated during ethanol withdrawal (Olive et al., 2002) and suggest that CIE can modulate normal CRF signaling in the BNST in vivo. CIE can increase CRFR1 sensitivity in other components of the extended amygdala after prolonged withdrawal (Roberto et al., 2010) , which might suggest that CRFR1 receptors in the BNST may also become sensitized following long-term withdrawal. In conjunction with the hypothesis that catecholamine-CRF interactions in the BNST may be critical for reinstatement, EtOH withdrawal-induced sensitization CRF circuitry in the BNST could be one mechanism for the long-term challenge of stress-induced relapse in recovering alcoholics (Sinha, 2007) .
Summary and conclusions
Our data indicate a putative two-step reinstatement circuit centered around CRFR1 activity in the BNST, wherein catecholamines can enhance activity of BNST CRF neurons that may in turn increase the excitability of BNST neurons that project to the VTA. While more work will be needed to conclusively show the exact mode of action of this circuitry during reinstatement, we hypothesize that engagement of this circuitry following exposure to drug-associated cues or stressors likely results in increased signaling from the BNST to the VTA, thereby driving drug seeking. While the data presented here focuses on the potential role of the BNST-CRF neurocircuitry in alcoholism, recent work indicates that this neurocircuitry may also be recruited following chronic cocaine (Nobis et al., 2011) or morphine exposure (Wang et al., 2006) . Together, these findings suggest that perturbations of BNST CRF signaling may be a common mechanism for relapse regardless of the drug abused. Future research identifying specific targets within this circuitry may improve strategies for more effective long-term treatment of alcohol and drug addiction.
